Cargando…

Back to the Future: Lessons Learned From the 1918 Influenza Pandemic

2018 marks the 100-year anniversary of the 1918 influenza pandemic, which killed ~50 million people worldwide. The severity of this pandemic resulted from a complex interplay between viral, host, and societal factors. Here, we review the viral, genetic and immune factors that contributed to the seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Short, Kirsty R., Kedzierska, Katherine, van de Sandt, Carolien E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187080/
https://www.ncbi.nlm.nih.gov/pubmed/30349811
http://dx.doi.org/10.3389/fcimb.2018.00343
_version_ 1783362963302776832
author Short, Kirsty R.
Kedzierska, Katherine
van de Sandt, Carolien E.
author_facet Short, Kirsty R.
Kedzierska, Katherine
van de Sandt, Carolien E.
author_sort Short, Kirsty R.
collection PubMed
description 2018 marks the 100-year anniversary of the 1918 influenza pandemic, which killed ~50 million people worldwide. The severity of this pandemic resulted from a complex interplay between viral, host, and societal factors. Here, we review the viral, genetic and immune factors that contributed to the severity of the 1918 pandemic and discuss the implications for modern pandemic preparedness. We address unresolved questions of why the 1918 influenza H1N1 virus was more virulent than other influenza pandemics and why some people survived the 1918 pandemic and others succumbed to the infection. While current studies suggest that viral factors such as haemagglutinin and polymerase gene segments most likely contributed to a potent, dysregulated pro-inflammatory cytokine storm in victims of the pandemic, a shift in case-fatality for the 1918 pandemic toward young adults was most likely associated with the host's immune status. Lack of pre-existing virus-specific and/or cross-reactive antibodies and cellular immunity in children and young adults likely contributed to the high attack rate and rapid spread of the 1918 H1N1 virus. In contrast, lower mortality rate in in the older (>30 years) adult population points toward the beneficial effects of pre-existing cross-reactive immunity. In addition to the role of humoral and cellular immunity, there is a growing body of evidence to suggest that individual genetic differences, especially involving single-nucleotide polymorphisms (SNPs), contribute to differences in the severity of influenza virus infections. Co-infections with bacterial pathogens, and possibly measles and malaria, co-morbidities, malnutrition or obesity are also known to affect the severity of influenza disease, and likely influenced 1918 H1N1 disease severity and outcomes. Additionally, we also discuss the new challenges, such as changing population demographics, antibiotic resistance and climate change, which we will face in the context of any future influenza virus pandemic. In the last decade there has been a dramatic increase in the number of severe influenza virus strains entering the human population from animal reservoirs (including highly pathogenic H7N9 and H5N1 viruses). An understanding of past influenza virus pandemics and the lessons that we have learnt from them has therefore never been more pertinent.
format Online
Article
Text
id pubmed-6187080
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61870802018-10-22 Back to the Future: Lessons Learned From the 1918 Influenza Pandemic Short, Kirsty R. Kedzierska, Katherine van de Sandt, Carolien E. Front Cell Infect Microbiol Cellular and Infection Microbiology 2018 marks the 100-year anniversary of the 1918 influenza pandemic, which killed ~50 million people worldwide. The severity of this pandemic resulted from a complex interplay between viral, host, and societal factors. Here, we review the viral, genetic and immune factors that contributed to the severity of the 1918 pandemic and discuss the implications for modern pandemic preparedness. We address unresolved questions of why the 1918 influenza H1N1 virus was more virulent than other influenza pandemics and why some people survived the 1918 pandemic and others succumbed to the infection. While current studies suggest that viral factors such as haemagglutinin and polymerase gene segments most likely contributed to a potent, dysregulated pro-inflammatory cytokine storm in victims of the pandemic, a shift in case-fatality for the 1918 pandemic toward young adults was most likely associated with the host's immune status. Lack of pre-existing virus-specific and/or cross-reactive antibodies and cellular immunity in children and young adults likely contributed to the high attack rate and rapid spread of the 1918 H1N1 virus. In contrast, lower mortality rate in in the older (>30 years) adult population points toward the beneficial effects of pre-existing cross-reactive immunity. In addition to the role of humoral and cellular immunity, there is a growing body of evidence to suggest that individual genetic differences, especially involving single-nucleotide polymorphisms (SNPs), contribute to differences in the severity of influenza virus infections. Co-infections with bacterial pathogens, and possibly measles and malaria, co-morbidities, malnutrition or obesity are also known to affect the severity of influenza disease, and likely influenced 1918 H1N1 disease severity and outcomes. Additionally, we also discuss the new challenges, such as changing population demographics, antibiotic resistance and climate change, which we will face in the context of any future influenza virus pandemic. In the last decade there has been a dramatic increase in the number of severe influenza virus strains entering the human population from animal reservoirs (including highly pathogenic H7N9 and H5N1 viruses). An understanding of past influenza virus pandemics and the lessons that we have learnt from them has therefore never been more pertinent. Frontiers Media S.A. 2018-10-08 /pmc/articles/PMC6187080/ /pubmed/30349811 http://dx.doi.org/10.3389/fcimb.2018.00343 Text en Copyright © 2018 Short, Kedzierska and van de Sandt. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Short, Kirsty R.
Kedzierska, Katherine
van de Sandt, Carolien E.
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title_full Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title_fullStr Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title_full_unstemmed Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title_short Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
title_sort back to the future: lessons learned from the 1918 influenza pandemic
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187080/
https://www.ncbi.nlm.nih.gov/pubmed/30349811
http://dx.doi.org/10.3389/fcimb.2018.00343
work_keys_str_mv AT shortkirstyr backtothefuturelessonslearnedfromthe1918influenzapandemic
AT kedzierskakatherine backtothefuturelessonslearnedfromthe1918influenzapandemic
AT vandesandtcaroliene backtothefuturelessonslearnedfromthe1918influenzapandemic